Tuesday, September 12, 2017 2:18:52 PM
Concerned about the 90 day PE's missing clinical significance in light of strong trends and one year data strengthening.
Cash burn is very high with the multiple trials and additional ancillary non stroke trials i.e. Gvhd and other immunological disorders
OS and Float not too bad for a start up company
Do like FDA SPA and Fast track and other EU and Japan expeditious review status for unmet disease states
Like the 10's of Billions market they are pursuing for stroke, MI's and others
Not sure what the specific MOA for Multistem is? I know it inhibits inflammatory mediators in the spleen for subsequent inhibition to the brain as well as Brain site specific inhibition to the ischemic area of the brain.
I "LOVE" the potential for a 36 hour duration of treatment intervention over the SOC current 4 to 6 hour Thrombolytic treatment
Will there be an interim readout on the Stroke trials?
How long are these trials until full completion. Are they going to wait for the one year morbidity/Mortality data, or will that be post approval P4 - like data?
Is there a high likelihood of another cash raise/dilution and perhaps R/S? in your analysis and opinion
I like the resume's of Management and the Board
Would it be prudent to continue and watch for a more attractive pps entry? We are currently at the 80% of the 52 week high (2.22) low
Still have more DD to do. Always appreciate your views, analysis and opinion CARS...as well as the rest of this Board...PRO's and CON"s..Thank you in Advance.....PEARSBY
FEATURED Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • Apr 22, 2024 8:49 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM